Cargando…

PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway

Colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer-related mortality worldwide. Even with advances in therapy, CRC mortality remains high. Therefore, there is an urgent need to develop effective therapeutics for CRC. PCTAIRE protein kinase 1 (PCTK1) is an atypical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Po-Li, Huang, Chien-Yu, Chang, Tung-Cheng, Lin, Jang-Chun, Lee, Cheng-Chin, Prince, G. M. Shazzad Hossain, Makondi, Precious Takondwa, Chui, Angelina Wong-Ying, Chang, Yu-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298136/
https://www.ncbi.nlm.nih.gov/pubmed/37373155
http://dx.doi.org/10.3390/ijms241210008
_version_ 1785064041267331072
author Wei, Po-Li
Huang, Chien-Yu
Chang, Tung-Cheng
Lin, Jang-Chun
Lee, Cheng-Chin
Prince, G. M. Shazzad Hossain
Makondi, Precious Takondwa
Chui, Angelina Wong-Ying
Chang, Yu-Jia
author_facet Wei, Po-Li
Huang, Chien-Yu
Chang, Tung-Cheng
Lin, Jang-Chun
Lee, Cheng-Chin
Prince, G. M. Shazzad Hossain
Makondi, Precious Takondwa
Chui, Angelina Wong-Ying
Chang, Yu-Jia
author_sort Wei, Po-Li
collection PubMed
description Colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer-related mortality worldwide. Even with advances in therapy, CRC mortality remains high. Therefore, there is an urgent need to develop effective therapeutics for CRC. PCTAIRE protein kinase 1 (PCTK1) is an atypical member of the cyclin-dependent kinase (CDK) family, and the function of PCTK1 in CRC is poorly understood. In this study, we found that patients with elevated PCTK1 levels had a better overall survival rate in CRC based on the TCGA dataset. Functional analysis also showed that PCTK1 suppressed cancer stemness and cell proliferation by using PCTK1 knockdown (PCTK1-KD) or knockout (PCTK1-KO) and PCTK1 overexpression (PCTK1-over) CRC cell lines. Furthermore, overexpression of PCTK1 decreased xenograft tumor growth and knockout of PCTK1 significantly increased in vivo tumor growth. Moreover, knockout of PCTK1 was observed to increase the resistance of CRC cells to both irinotecan (CPT-11) alone and in combination with 5-fluorouracil (5-FU). Additionally, the fold change of the anti-apoptotic molecules (Bcl-2 and Bcl-xL) and the proapoptotic molecules (Bax, c-PARP, p53, and c-caspase3) was reflected in the chemoresistance of PCTK1-KO CRC cells. PCTK1 signaling in the regulation of cancer progression and chemoresponse was analyzed using RNA sequencing and gene set enrichment analysis (GSEA). Furthermore, PCTK1 and Bone Morphogenetic Protein Receptor Type 1B (BMPR1B) in CRC tumors were negatively correlated in CRC patients from the Timer2.0 and cBioPortal database. We also found that BMPR1B was negatively correlated with PCTK1 in CRC cells, and BMPR1B expression was upregulated in PCTK1-KO cells and xenograft tumor tissues. Finally, BMPR1B-KD partially reversed cell proliferation, cancer stemness, and chemoresistance in PCTK1-KO cells. Moreover, the nuclear translocation of Smad1/5/8, a downstream molecule of BMPR1B, was increased in PCTK1-KO cells. Pharmacological inhibition of Smad1/5/8 also suppressed the malignant progression of CRC. Taken together, our results indicated that PCTK1 suppresses proliferation and cancer stemness and increases the chemoresponse of CRC through the BMPR1B–Smad1/5/8 signaling pathway.
format Online
Article
Text
id pubmed-10298136
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102981362023-06-28 PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway Wei, Po-Li Huang, Chien-Yu Chang, Tung-Cheng Lin, Jang-Chun Lee, Cheng-Chin Prince, G. M. Shazzad Hossain Makondi, Precious Takondwa Chui, Angelina Wong-Ying Chang, Yu-Jia Int J Mol Sci Article Colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer-related mortality worldwide. Even with advances in therapy, CRC mortality remains high. Therefore, there is an urgent need to develop effective therapeutics for CRC. PCTAIRE protein kinase 1 (PCTK1) is an atypical member of the cyclin-dependent kinase (CDK) family, and the function of PCTK1 in CRC is poorly understood. In this study, we found that patients with elevated PCTK1 levels had a better overall survival rate in CRC based on the TCGA dataset. Functional analysis also showed that PCTK1 suppressed cancer stemness and cell proliferation by using PCTK1 knockdown (PCTK1-KD) or knockout (PCTK1-KO) and PCTK1 overexpression (PCTK1-over) CRC cell lines. Furthermore, overexpression of PCTK1 decreased xenograft tumor growth and knockout of PCTK1 significantly increased in vivo tumor growth. Moreover, knockout of PCTK1 was observed to increase the resistance of CRC cells to both irinotecan (CPT-11) alone and in combination with 5-fluorouracil (5-FU). Additionally, the fold change of the anti-apoptotic molecules (Bcl-2 and Bcl-xL) and the proapoptotic molecules (Bax, c-PARP, p53, and c-caspase3) was reflected in the chemoresistance of PCTK1-KO CRC cells. PCTK1 signaling in the regulation of cancer progression and chemoresponse was analyzed using RNA sequencing and gene set enrichment analysis (GSEA). Furthermore, PCTK1 and Bone Morphogenetic Protein Receptor Type 1B (BMPR1B) in CRC tumors were negatively correlated in CRC patients from the Timer2.0 and cBioPortal database. We also found that BMPR1B was negatively correlated with PCTK1 in CRC cells, and BMPR1B expression was upregulated in PCTK1-KO cells and xenograft tumor tissues. Finally, BMPR1B-KD partially reversed cell proliferation, cancer stemness, and chemoresistance in PCTK1-KO cells. Moreover, the nuclear translocation of Smad1/5/8, a downstream molecule of BMPR1B, was increased in PCTK1-KO cells. Pharmacological inhibition of Smad1/5/8 also suppressed the malignant progression of CRC. Taken together, our results indicated that PCTK1 suppresses proliferation and cancer stemness and increases the chemoresponse of CRC through the BMPR1B–Smad1/5/8 signaling pathway. MDPI 2023-06-11 /pmc/articles/PMC10298136/ /pubmed/37373155 http://dx.doi.org/10.3390/ijms241210008 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wei, Po-Li
Huang, Chien-Yu
Chang, Tung-Cheng
Lin, Jang-Chun
Lee, Cheng-Chin
Prince, G. M. Shazzad Hossain
Makondi, Precious Takondwa
Chui, Angelina Wong-Ying
Chang, Yu-Jia
PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway
title PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway
title_full PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway
title_fullStr PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway
title_full_unstemmed PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway
title_short PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway
title_sort pctaire protein kinase 1 (pctk1) suppresses proliferation, stemness, and chemoresistance in colorectal cancer through the bmpr1b-smad1/5/8 signaling pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298136/
https://www.ncbi.nlm.nih.gov/pubmed/37373155
http://dx.doi.org/10.3390/ijms241210008
work_keys_str_mv AT weipoli pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT huangchienyu pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT changtungcheng pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT linjangchun pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT leechengchin pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT princegmshazzadhossain pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT makondiprecioustakondwa pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT chuiangelinawongying pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway
AT changyujia pctaireproteinkinase1pctk1suppressesproliferationstemnessandchemoresistanceincolorectalcancerthroughthebmpr1bsmad158signalingpathway